Related Experiment Video
Updated: Jul 11, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Residual renal function plays an important role in regulating parathyroid hormone in patients on continuous
Saiko Okada1, Tsutomu Inoue, Hidetomo Nakamoto
1Kidney Disease Center, Saitama Medical University, Saitama, Japan.
Insights
Hyperparathyroidism is a growing concern for patients on continuous ambulatory peritoneal dialysis (CAPD). Declining residual renal function (RRF) in CAPD patients is linked to impaired calcium and phosphate metabolism.
Area of Science:
- Nephrology
- Endocrinology
- Metabolic Bone Disease
Background:
- Hyperparathyroidism was historically less problematic in continuous ambulatory peritoneal dialysis (CAPD) patients.
- It has become a significant cardiovascular concern in end-stage renal disease (ESRD) patients, including those on CAPD, due to serum phosphate and calcium disturbances.
- The Ca x P product is a critical factor in this progression.
Purpose of the Study:
- To retrospectively evaluate the clinical course of hyperparathyroidism in CAPD patients.
- To investigate the relationship between residual renal function (RRF) and mineral metabolism in these patients.
Main Methods:
- Retrospective analysis of 17 patients undergoing CAPD between April 1995 and September 2003.
- Evaluation of serum calcium, phosphate, and intact parathyroid hormone levels.
- Assessment of residual renal function (RRF) decline.
Main Results:
- All 17 patients experienced a decline in RRF over their clinical course.
- Declining RRF showed a significant negative correlation with serum calcium and intact parathyroid hormone levels.
- Three patients required parathyroidectomy.
Conclusions:
- Residual renal function (RRF) plays a crucial role in regulating calcium-phosphate (Ca-P) metabolism in patients on CAPD.
- Monitoring RRF is essential for managing hyperparathyroidism in CAPD patients.
- Further research into RRF's impact on mineral metabolism is warranted.
Abstract:
In the past, hyperparathyroidism was not generally a major problem in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). However, in conjunction with disturbances in serum phosphate, Ca, and CaxP product, hyperparathyroidism has become a serious problem in the cardiovascular diseases of patients with end-stage renal disease-even patients undergoing CAPD. We retrospectively evaluated the first 5 years on CAPD for 17 patients who started and continued dialysis between April 1995 and September 2003. Of these 17 patients, 3 underwent parathyroidectomy. During their clinical course, all of the patients experienced a decline in residual renal function (RRF) that was significantly negatively correlated with their levels of serum Ca and intact parathyroid hormone. Based on these findings, we suggest that RRF is an important factor for the regulation of Ca-P metabolism in patients on CAPD.
Related Concept Videos
Continuous Renal Replacement Therapy
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Peritoneal Dialysis III: Nursing Management

